Abstract:Next generation sequencing (NGS) has provided biologists with an unprecedented view into biological processes and their regulation over the past 2 decades, fueling a wave of development of high throughput methods based on short read DNA and RNA sequencing. For nucleic acid modifications, NGS has been coupled with immunoprecipitation, chemical treatment, enzymatic treatment, and/or the use of reverse transcriptase enzymes with fortuitous activities to enrich for and to identify covalent modifications of RNA and DNA. However, the majority of nucleic acid modifications lack commercial monoclonal antibodies, and mapping techniques that rely on chemical or enzymatic treatments to manipulate modification signatures add additional technical complexities to library preparation. Moreover, such approaches tend to be specific to a single class of RNA or DNA modification, and generate only indirect readouts of modification status. Third generation sequencing technologies such as the commercially available "long read" platforms from Pacific Biosciences and Oxford Nanopore Technologies are an attractive alternative for high throughput detection of nucleic acid modifications. While the former can indirectly sense modified nucleotides through changes in the kinetics of reverse transcription reactions, nanopore sequencing can in principle directly detect any nucleic acid modification that produces a signal distortion as the nucleic acid passes through a nanopore sensor embedded within a charged membrane. To date, more than a dozen endogenous DNA and RNA modifications have been interrogated by nanopore sequencing, as well as a number of synthetic nucleic acid modifications used in metabolic labeling, structure probing, and other emerging applications. This review is intended to introduce the reader to nanopore sequencing and key principles underlying its use in direct detection of nucleic acid modifications in unamplified DNA or RNA samples, and outline current approaches for detecting and quantifying nucleic acid modifications by nanopore sequencing. As this technology matures, we anticipate advances in both sequencing chemistry and analysis methods will lead to rapid improvements in the identification and quantification of these epigenetic marks.

Labeling and Sequencing Nucleic Acid Modifications Using Bio-Orthogonal Tools

Isocyanides: Promising Functionalities in Bioorthogonal Labeling of Biomolecules

Determining RNA Natural Modifications and Nucleoside Analog-Labeled Sites by a Chemical/Enzyme-Induced Base Mutation Principle

Bioorthogonal chemistry-based RNA labeling technologies: evolution and current state

Progress in the Bioorthogonal Labeling Reactions

A Bioorthogonal Ligation Enabled By Click Cycloaddition Of O-Quinolinone Quinone Methide And Vinyl Thioether

Bioorthogonal metabolic cellular DNA labelling using vinyl thioether modified thymidine and o-quinolinone quinone methide.

Ortho-Quinone Methide Finds Its Application in Bioorthogonal Ligation

Bioorthogonally activated probes for precise fluorescence imaging

Development Of Bioorthogonal Reactions And Their Applications In Bioconjugation

Cellular Metabolic Labeling of Nucleic Acids and Its Applications

Bioorthogonal Reactions in Bioimaging

Cyclopropenes as Chemical Reporters for Dual Bioorthogonal and Orthogonal Metabolic Labelling of DNA

Recent Progress of Bioorthogonal Chemistry in China

Visualizing Newly Synthesized RNA by Bioorthogonal Labeling-Primed DNA Amplification

Bioorthogonal Ligation and Cleavage by Reactions of Chloroquinoxalines with Ortho ‐Dithiophenols

Applications of Nanopore Sequencing Technology in the Detection of Nucleic Acid Modifications

Modification mapping by nanopore sequencing

Development and Applications of Bioorthogonal Cleavage Reactions

Direct, Quantitative, and Base‐Resolution Sequencing of DNA and RNA Modifications

Bioorthogonal Ligations and Cleavages in Chemical Biology